TherapeuticsMD
TXMD
#10160
Rank
โ‚ฌ17.29 M
Marketcap
1,49ย โ‚ฌ
Share price
8.07%
Change (1 day)
28.37%
Change (1 year)

Revenue for TherapeuticsMD (TXMD)

Revenue in 2025 (TTM): โ‚ฌ2.3 Million

According to TherapeuticsMD's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.19 Million. In 2024 the company made a revenue of โ‚ฌ1.69 Million an increase over the revenue in the year 2023 that were of โ‚ฌ1.17 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TherapeuticsMD from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ2.3 M36.09%
2024 โ‚ฌ1.69 M43.68%
2023 โ‚ฌ1.17 M-50.44%
2022 โ‚ฌ2.37 M-96.9%
2021 โ‚ฌ76.77 M45.57%
2020 โ‚ฌ52.74 M19.01%
2019 โ‚ฌ44.31 M214.92%
2018 โ‚ฌ14.07 M0.64%
2017 โ‚ฌ13.98 M-24.01%
2016 โ‚ฌ18.4 M-0.11%
2015 โ‚ฌ18.42 M49.11%
2014 โ‚ฌ12.35 M94.43%
2013 โ‚ฌ6.35 M120.15%
2012 โ‚ฌ2.88 M3.55%
2011 โ‚ฌ2.78 M18107.21%
2010 โ‚ฌ0.01 M107.53%
2009 โ‚ฌ0 M
2006 โ‚ฌ0.76 M-2.86%
2005 โ‚ฌ0.78 M70.55%
2004 โ‚ฌ0.45 M32.3%
2003 โ‚ฌ0.34 M26.77%
2002 โ‚ฌ0.27 M-27.19%
2001 โ‚ฌ0.37 M-3.6%
2000 โ‚ฌ0.39 M83.76%
1999 โ‚ฌ0.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agile Therapeutics
AGRX
โ‚ฌ18.52 M 742.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
โ‚ฌ0.26 B 12,040.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 2,453,436.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.22 B 2,330,654.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ2.01 B 91,726.65%๐Ÿ‡ฌ๐Ÿ‡ง UK